Comparison between single subcutaneous glargine injection and continuous regular insulin infusion for glycemic control in critically ill patients

Phase 2

Completed

• Conditions: To determine whether a single subcutaneous glargine injection with 100% dose transition is not inferior to continuous regular insulin (RI) infusion for blood glucose control in critically ill patients; Glycemic control, regular insulin, insulin glargine

• Registration Number: TCTR20160126004
• Lead Sponsor: il

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-12-25
• Study Start: 2016-01-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Adult patient with
-admitted to the intensive care unit with hyperglycemia and required insulin infusion (blood glucose>=140 mg/dL)
-required constant rate of continuous regular insulin infusion for 12 consecutive hours
-previous 12 hours blood glucose level were in the proper range (80-200 mg/dL)
-trend to receive constant glucose intake rate

Exclusion Criteria

Adult patient who
-trend to change in glucose intake rate
-deteriorated hemodynamic status
-diabetic ketoacidosis or hyperosmolar coma

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose level every 2 hours for 24 hours 24 hours Blood sugar mg/dl

Secondary Outcome Measures

Name	Time	Method
nil nil nil